Five hundred intestinal and multivisceral transplantations at a single center: Major advances with new challenges

Annals of Surgery

Volumn 250, Issue 4, 2009, Pages 567-580

  Abu Elmagd, Kareem M ^a   Costa, Guilherme ^a   Bond, Geoffrey J ^a   Soltys, Kyle ^a   Sindhi, Rakesh ^a   Wu, Tong ^a   Koritsky, Darlene A ^a   Schuster, Bonita ^a   Martin, Lillian ^a   Cruz, Ruy J ^a   Murase, Noriko ^a   Zeevi, Adriana ^a   Irish, William ^b   Ayyash, Maher O ^a   Matarese, Laura ^a   Humar, Abhinav ^a   Mazariegos, George ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b CTI Clinical Trial and Consulting Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DACLIZUMAB; DEXAMETHASONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADD ON THERAPY; ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; BONE MARROW; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEASIBILITY STUDY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INTESTINES; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS; REOPERATION; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; VISCERA;

EID: 70349705658     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181b67725     Document Type: Article

References (51)

1. Lillehei RC, Goott B, Miller FA. Homografts of the small bowel. Surg Forum. 1959;10:197.
2. Starzl TE, Kaupp HA, Brock DR, et al. Mass homotransplantation of abdominal organs in dogs. Surg Forum. 1960;11:28-30.
3. Kirkman RL. Small bowel transplantation. Transplantation. 1984;37:429-433.
4. Starzl TE, Rowe MI, Todo S, et al. Transplantation of multiple abdominal viscera. JAMA. 1989;261:1449-1457.
5. Abu-Elmagd K. The history of intestinal transplantation. In: Nakim NS, Papalois VE, eds. The History of Organ and Cell Transplantation. London: Imperial College Press; 2003:171-193.
6. Starzl TE, Todo S, Fung J, et al. FK 506 for human liver, kidney and pancreas transplantation. Lancet. 1989;2:1000-1004.
7. Abu-Elmagd KM, Costa G, Bond GJ, et al. Evolution of the immunosup-pressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance. Transpl Int. 2009;22:96-109.
8. Fishbein T, Novitskiy G, Mishra L, et al. NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut. 2008;57:323-330.
9. Starzl TE, Todo S, Tzakis A, et al. The many faces of multivisceral transplantation. Surg Gynecol Obstet. 1991;172:335-344.
10. Abu-Elmagd KM. Preservation of the native spleen, duodenum, and pancreas in patients with multivisceral transplantation: nomenclature, dispute of origin, and proof of premise. Transplantation. 2007;84:1208-1209.
11. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology. 1993; 17:1127-1152.
12. Starzl TE, Zinkernagel RM. Transplantation tolerance from a historical perspective. Nat Rev Immunol. 2001;1:233-239.
13. Todo S, Reyes J, Furukawa H, et al. Outcome analysis of 71 clinical intestinal transplantations. Ann Surg. 1995;222:270-282.
14. Abu-Elmagd K, Reyes J, Bond G, et al. Clinical intestinal transplantation: a decade of a single center experience. Ann of Surg. 2001;234:404-417.
15. Casavilla A, Selby R, Abu-Elmagd K, et al. Logistics and technique for combined hepatic-intestinal retrieval. Arch Surg. 1992;216:605-609.
16. Abu-Elmagd KM, Fung JJ, Bueno J, et al. Logistics and technique for procurement of intestinal, pancreatic, and hepatic grafts from the same donor. Ann of Surg. 2000;232:680-687.
17. Abu-Elmagd K, Reyes J, Todo S, et al. Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg. 1998;186: 512-527.
18. Reyes J, Fishbein T, Bueno J, et al. Reduced-size orthotopic composite liver-intestinal allograft. Transplantation. 1998;66:489-492.
19. Bueno J, Abu-Elmagd K, Mazariegos G, et al. Composite liver-small bowel allografts with preservation of donor duodenum and hepatic biliary system in children. J Pediatr Surg. 2000;32:291-296.
20. Abu-Elmagd KM, Bond G, Reyes J, et al. Intestinal transplantation: a coming of age. Adv Surg. 2002;36:65-101.
21. Todo S, Tzakis AG, Abu-Elmagd K, et al. Intestinal transplantation in composite visceral grafts or alone. Ann Surg. 1992;216:223-234.
22. Todo S, Tzakis AG, Abu-Elmagd K, et al. Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation. 1992;53:369-376.
23. Abu-Elmagd K, Todo S, Tzakis A, et al. Three years clinical experience with intestinal transplantation. J Am Coll Surg. 1994;179:385-400. (Pubitemid 24314542)
24. Todo S, Tzakis A, Reyes J, et al. Small intestinal transplantation in humans with or without colon. Transplantation. 1994;57:840-848. (Pubitemid 24114674)
25. Todo S, Tzakis A, Abu-Elmagd K, et al. Abdominal multivisceral transplantation. Transplantation. 1995;59:234-240.
26. Tzakis AG, Nour B, Reyes J, et al. Endorectal pull-through of transplanted colon as part of intestinal transplantation. Surgery. 1995;117:451-453.
27. Tzakis AG, Todo S, Reyes J, et al. Piggyback orthotopic intestinal transplantation. Surg Gynecol Obstet. 1993;176:297-298.
28. Reyes J, Mazariegos G, Abu-Elmagd K, et al. Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (Thymoglobulin). Am J Transplant. 2005;5:1430-1436.
29. Abu-Elmagd KM, Tzakis A, Todo S, et al. Monitoring and treatment of intestinal allograft rejection in humans. Transplant Proc. 1993;25:1202-1203.
30. Lee RG, Nakamura K, Tsamandas AC, et al. Pathology of human intestinal transplanation. Gastroenterology. 1996;110:1820-1834.
31. Thiede C, Florek M, Bornhauser M, et al. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant. 1999;23:1055-1060.
32. Rovera GM, Schoen RE, Goldbach B, et al. Intestinal and multivisceral transplantation: Dynamics of nutritional management and functional autonomy. JPEN J Parenter Enteral Nutr. 2003;27:252-259.
33. Reyes J, Tzakis AG, Todo S, et al. Nutritional management of intestinal transplant recipients. Transplant Proc. 1993;25:1200-1201.
34. Abu-Elmagd K, Todo S, Tzakis A, et al. An isolated complete intestinal transplantation in an adult: a complicated postoperative course. Transplant Sci. 1992;2:23-27.
35. Green M, Reyes J, Rowe D, et al. New strategies in the prevention and management of epstein-barr virus infection and posttransplant lymphoprolif-erative disease following solid organ transplanatin. Curr Opin Organ Transplant. 1998;3:143.
36. Grant D, Abu-Elmagd K, Reyes J, et al. 2003 Report of the intestine transplant registry: a new era has dawned. Ann Surg. 2005;241:607-613.
37. Tzakis AG, Kato T, Levi DM, et al. 100 Multivisceral transplants at a single center. Ann Surg. 2005;242:480-493.
38. Mazariegos GV, Soltys K, Bond G, et al. Pediatric intestinal retransplanta-tion: techniques, management, and outcomes. Transplantation. 2008;86: 1777-1782.
39. Goulet O, Lacaille F, Colomb V, et al. Intestinal transplantation in children: Paris experience. Transplant Proc. 2002;34:1887-1888. (Pubitemid 34895362)
40. Fishbein TM, Kaufmann SS, Florman SS, et al. Isolated intestinal transplantation: proof of clinical efficacy. Transplantation. 2003;76:636-640.
41. Farmer DG, McDiarmid SV, Yersiz H, et al. Outcomes after intestinal transplantation: a single-center experience over a decade. Transplant Proc. 2002;34:896-897. (Pubitemid 34556846)
42. de Ville G, Mitchell A, Mayer AD, et al. En block combined reduced-liver and small bowel transplants: from large donors to small children. Transplantation. 2000;69:555-559.
43. Abu-Elmagd K, Fung J, McGhee W, et al. The efficacy of daclizumab for intestinal transplantation: preliminary report. Transplant Proc. 2000;32:1195
44. Carreno MR, Kato T, Weppler D, et al. Induction therapy with daclizumab as part of the immunosuppressive regimen in human small bowel and multiorgan transplants. Transplant Proc. 2001;33:1015-1017.
45. Tzakis AG, Kato T, Nishida S, et al. Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation. Transplantation. 2003;75:1227-1231.
46. Starzl TE, Murase N, Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet. 2003;361:1502-1510.
47. Berney T, Kato T, Nishida S, et al. Portal versus systemic drainage of small bowel allografts: comparative assessment of survival, function, rejection, and bacterial translocation. J Am Coll Surg. 2002;195:804-813. (Pubitemid 35470890)
48. Calne RY, Sells RA, Pena JR, et al. Induction of immunological tolerance by procine liver allografts. Nature. 1969;223:472.
49. Kamada N. The immunology of experimental liver transplantation in the rat. Immunology. 1985;55:369-389.
50. Kato T, Tzakis AG, Selvaggi G, et al. Transplantation of the spleen: effect of splenic allograft in human multivisceral transplantation. Ann of Surg. 2007; 246:436-444.
51. Iwaki Y, Starzl TE, Yagihashi A, et al. Replacement of donor lymphoid tissue in human small bowel transplants under FK 506 immunosuppression. Lancet. 1991;337:818-819.